首页|谷氨酰胺酶1抑制剂对四氯化碳诱导的小鼠肝纤维化的影响

谷氨酰胺酶1抑制剂对四氯化碳诱导的小鼠肝纤维化的影响

扫码查看
目的 探讨谷氨酰胺酶 1(glutaminase 1,GLS1)特异性抑制剂 BPTES[bis-2-(5-phenylacetamido-1,3,4-thiadia-zol-2-yl)ethyl sulfide]对四氯化碳(carbon tetrachloride,CC14)诱导的小鼠肝纤维化模型肝纤维化的影响.方法 经雄性C57BL/6J小鼠腹腔注射橄榄油(对照组)、10%CCl4(10 μL/g,模型组)或10%CCl4(10 μL/g)+BPTES(10 mg/kg,处理组),每组10只,每周注射2次,共4周,构建肝纤维化模型.采用天狼猩红染色法观察小鼠肝脏组织中胶原沉积情况;qRT-PCR和免疫组织化学染色法检测小鼠肝脏组织中肌动蛋白2(actin alpha 2,Acta2)、Ⅰ型胶原α1(collagen type Ⅰ alpha 1,Col1α1)、GLS1基因及GLS1蛋白表达水平.结果 与对照组小鼠相比,模型组小鼠肝脏组织整体增大,表面不光滑,呈颗粒状,同时肝脏质量与胫骨长度比显著增加(t=2.979,P<0.05);与对照组相比,模型组小鼠肝脏组织中天狼猩红染色阳性的胶原沉积面积显著增加(t=7.661,P<0.01),Acta2和Col1α1基因相对表达量均显著增加(t分别为4.335和5.319,P均<0.01),GLS1 mRNA和蛋白表达水平均显著增加(t分别为5.319和9.725,P<0.01);与模型组小鼠相比,BPTES处理组小鼠肝脏质量减轻,肝脏组织中天狼猩红染色阳性的胶原沉积面积显著减少(t=7.427,P<0.01),Atca2和Col1a1基因相对表达量均显著降低(t分别为3.713和2.628,P均<0.05).结论 抑制GLS1活性可显著改善CC14诱导的肝纤维化程度,为肝纤维化治疗提供了新思路.
Effect of glutaminase 1 inhibitor on carbon tetrachloride-induced liver fibrosis in mice
Objective To investigate the effect of glutaminase 1(GLS1)specific inhibitor BPTES[bis-2-(5-phenylaceta-mido-1,3,4-thiadiazol-2-yl)ethyl sulfide]on the liver fibrosis in the mouse model of liver fibrosis induced by carbon tetrachloride(CCl4).Methods Male C57BL/6J mice were intraperitoneally injected with olive oil(control group),10%CC14(10 μL/g,model group)or 10%CC14(10 µL/g)+BPTES(10 mg/kg,treatment group),with 10 mice in each group,two doses a week for four weeks to establish liver fibrosis model.Collagen deposition in mouse liver tissue was observed by Sirius red staining.The expression levels of actin alpha 2(Acta2),collagen type Ⅰ alpha 1(Collαl)GLS1 and GLS1 protein were detected by qRT-PCR and immunohistochemical staining.Results Compared with the control group,the liver tissue of mice in the model group was generally enlarged,the surface was not smooth and granular,and the ratio of liver mass to tibia length significantly increased(t=2.979,P<0.05);The Sirius red positive area of collagen deposition increased signifi-cantly in the liver tissue of mice in the model group(t=7.661,P<0.01),the relative expression levels of Acta2 and Col1α1 significantly increased(t=4.335 and 5.319,respectively,each P<0.01),and the mRNA and protein levels of GLS1 significantly increased(t=5.319 and 9.725,respectively,each P<0.01).However,compared with the model group,the BPTES treatment group had a reduction in liver mass,a significant reduction in the Sirius red positive area of collagen deposition in liver tissue(t=7.427,P<0.01),and a significant reduction in the relative expressions of Atca2 and Col1a1(t=3.713 and 2.628,respectively,each P<0.05).Conclusion Inhibition of GLS1 activity can significantly improve the degree of liver fibrosis induced by CC14,providing a new idea for the treatment of liver fibrosis.

Liver fibrosisAnimal modelGlutaminase(GLS)InhibitorBPTESCollagen

王晓、张聪聪、张燕红、洪诗瑶、杜杰

展开 >

山西医科大学第一医院核医学科,山西太原 030001

首都医科大学附属北京安贞医院 北京市心肺血管疾病研究所血管生物学研究室,北京 100029

肝纤维化 动物模型 谷氨酰胺酶 抑制剂 BPTES 胶原

国家自然科学基金国家自然科学基金北京市自然科学基金

8193001482272477Z200026

2024

中国生物制品学杂志
中华预防医学会,长春生物制品研究所有限责任公司

中国生物制品学杂志

CSTPCD
影响因子:0.417
ISSN:1004-5503
年,卷(期):2024.37(2)
  • 25